Pharmaceuticals

Global Urokinase Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-19563486 | Published Date: 18-Nov-2021 | No. of pages: 117

Description

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The Urokinase market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Urokinase market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Urokinase Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Urokinase market are:
Mayne Pharma Inc
Teva
Pfizer
Taj Pharma
Novartis
Microbix Biosystems Inc
NDPHARM
PKU High-Tech Huatai Pharmaceutica
Tianjin Biochem Pharmaceutical
Abbott
Liaoning Weixing Pharmaceutical
Sandoz
Suzhou No.1 Pharmaceutical
Bharat Biotech
United Biotech
JCR Pharmaceuticals
Takeda
Mylan
Emcure
Livzon Pharmaceutical Group
Squibb
Zydus Cadila

Most important types of Urokinase products covered in this report are:
Urokinase Powder
Urokinase Solution

Most widely used downstream fields of Urokinase market covered in this report are:
Hospital use
Clinic
Others

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.